Dr. Geetha Puthenveetil, Pediatric Hematology
Dr. Geetha Putheveetil specializes in all aspects of hematology with emphasis in hemoglobinopathies, including beta thalassemia and sickle cell disease, and is part of the national sickle cell network. She is currently part of an international study looking at standards of care with sickle cell patients. Helping to facilitate this research, Dr. Putheveetil established a comprehensive red cell clinic at CHOC to treat patients with red cell disorders—including sickle cell disease, thalassemia, aplastic anemia, and Diamond-Blackfan Anemia. The clinic is attended by a cardiologist, endocrinologist, and hematologist and provides comprehensive care for patients. Dr. Puthenveetil is board certified in pediatrics and pediatric hematology-oncology. Prior to joining CHOC, Dr. Puthenveetil attended medical school in India at St. John’s Medical College. She served her pediatric residency training at St. John’s Medical College Hospital and at New York Medical College in Valhalla, New York and completed a pediatric hematology-oncology fellowship at Children’s Hospital Los Angeles/University of Southern California. Dr. Puthenveetil was voted as one of Orange County’s Top Doctors and speaks fluent Hindi and Malayalam.
Hemoglobinopathies, Sickle Cell disease
Sickle cell disorders
1201 W. La Veta Ave. Building: CHOC Clinic
Orange, CA 92868
St Joseph Hospital
1100 W Stewart Dr
Orange, CA 92868
- Medical School
St John’s Medical College, Bangalore, Karnataka, India
- Pediatric Hematology/Oncology Fellowship
Children’s Hospital of Los Angeles, CA
- Pediatrics Residency
New York Medical College/Westchester Medical Center, Valhalla, NY
- Assistant Clinical Professor
- Hematology, CHOC Specialists
Honors and Awards
- Excellence in Research Award from the American Society of Gene Therapy in 2004
- Physician of Excellence
OCMA, Multiple years
Presentations and Abstracts
David Shyr MD, Geetha Puthenveetil MD, CHOC Hospital in Orange. Abstract accepted for a poster presentation at the Annual meeting of the American Society of Pediatric Hematology/Oncology in April 2010
Jill Stites FNP, Geetha Puthenveetil MD, CHOC Hospital in Orange. Abstract accepted for a poster presentation at the Annual meeting of the American Society of Pediatric Hematology/Oncology in April 2010
“Poster presentation” Ninth Cooley’s Anemia Symposium, 10/09
In 2010 at the annual meeting for the American Society of Pediatric Hematology/Oncology, Dr. Petheveetil coauthored the poster presentations accepted for publication in Pediatric Transplantation, the official journal of the International Pediatric Transplant Association.
Aimee Foord, Elyssa Rubin, Daniel Leino, Anita Gupta, Geetha Puthenveetil. A Rare Presentation of Sarcoma. ASPHO. 2015; Abstract.
Tami John, Carol Lin, Aaron Sassoon, Geetha Puthenveetil, David Buchbinder. Large Granular Lymphocyte Leukemia Presenting in Adolescence. ASPHO. 2015; Abstract.
Geetha Puthenveetil, Jill Stites. Treatment Strategies for Airway Hemangiomas. ASPHO. 2015; Abstract.
Geetha Puthenveetil, Jill Stites, Kevin Huoh, Michael Recto, John Stuart Nelson, Daniel Jaffurs. Parotid hemangiomas need a longer treatment course for resolution. ISSVA. 2016; Abstract.
- American Society of Pediatric Hematology/Oncology
Unrelated Hematopoietic Stem Cell Transplantation in a patient with Congenital Dyserythropoietic Anemia and Iron Overload. Buchbinder D, Nugent D, Vu D, Soni A, Stites J, Hsieh L, Puthenveetil G. Pediatr Transplant. 2010 Nov 26. (Epub ahead of print) PMID 21108711 [PubMed as supplied by publisher]
Inflammatory Polyps following successful HLA-matched cord blood transplantation in a patient with X-linked lymphoproliferative syndrome. Buchbinder D, Younes B, Sassoon A, Soni A, Hsieh L, Puthenveetil G, Stites J, Ness-Jorden T, Neudorf S, Nugent D. Pediatr Transplant 2011 July 8. (Epub ahead of print). PMID 21736679 [PubMed “ as supplied by publisher]
Reiss UM, Schwartz J, Sakamoto KM, Puthenveetil G, Ogawa M, Bedrosian CL, Ware RE. Efficacy and safety of eculizumab in children and adolescents with paroxysmal nocturnal hemoglobinuria. Pediatr Blood Cancer. 2014; 61(9):1544-50. doi: 10.1002/pbc.25068.
Buchbinder D, Hsieh L, Mahajerin A, Puthenveetil G, Soni A, Nugent D. Successful treatment of secondary graft failure following unrelated cord blood transplant with hematopoietic growth factors in a pediatric patient with Fanconi anemia. Pediatr Transplant. 2015; 19(7):E181-4. doi: 10.1111/petr.12564.
Dr. Putheveetil is part of the national sickle cell network. She is currently part of an international study looking at standards of care with sickle cell patients. Helping to facilitate this research, Dr. Putheveetil established a comprehensive red cell clinic at CHOC to treat patients with red cell disorders including sickle cell disease, thalassemia, aplastic anemia, and Diamond-Blackfan Anemia. The clinic is attended by a cardiologist, endocrinologist, and hematologist and provides comprehensive care for patients.
Our hematologists commonly treat:
- Anemia, including sickle cell anemia, thalassemia, iron deficiency and lead toxicity
- White cell and immune deficiency disorders
- Aplastic anemia
- Bone marrow failure syndromes
- Vascular malformation/hemangiomas
- Platelet disorders
- Coagulation abnormalities, hemophilia, Von Willebrand’s disease, rare bleeding disorders such as Factor 13 deficiency
- Excessive clotting disorders, thrombophilia, deep venous clots, pulmonary embolus or stroke
- Acquired bleeding and clotting disorders
- Prevention of bleeding and clotting problems, with particular experience for patients on cardiopulmonary bypass
- Office: 714-509-8459
- Specialty: Hematology
- Board Certified: Pediatrics, Pediatric Hematology/Oncology
- Additional Languages: Hindi
- On Staff at: CHOC Children's Hospital
In this segment of American Health Journal, Geetha Puthenveetil, MD, explains the disorder of sickle cell anemia & about most common myths of the disease.